Viewing nowMyungmoon Atorvastatin Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 201307483 · Approved 2013.05.27 · Insurance code 649806280
Reduction of risks of myocardial infarction and stroke and improvement of high cholesterol.
This medication helps reduce the risks of cardiovascular diseases. It is especially effective in reducing the risk of myocardial infarction and stroke in adults with multiple risk factors and patients with type 2 diabetes, as well as reducing the risks of vascular interventions and angina. Additionally, it is effective in lowering the risk of myocardial infarction, stroke, and hospitalization due to congestive heart failure in patients who already have coronary heart disease, and alleviating the symptoms of angina. It is also used in the treatment of hyperlipidemia, decreasing levels of LDL cholesterol, total cholesterol, and triglycerides, and increasing HDL cholesterol even when dietary measures are ineffective. For pediatric patients aged 10 to 17 years with familial hypercholesterolemia, it aids in improving blood lipid levels as an adjunct to dietary therapy. This medication is effectively used for reducing cardiovascular disease risks and improving blood lipid levels.
The recommended initial dose for hyperlipidemia is 10 mg once daily; for patients requiring more significant reductions in LDL cholesterol, it may start at 20 mg or 40 mg once daily (only if more than a 45% reduction in LDL cholesterol is required). The dosing can be individualized within the range of 10 to 80 mg once daily. Patients with homozygous familial hypercholesterolemia may receive 10 to 80 mg once daily, with the possibility of combined use with other lipid-lowering therapies as needed.
The recommended initial dose for pediatric patients (ages 10 to 17) with heterozygous familial hypercholesterolemia is 10 mg once daily, with a recommended maximum dose of 20 mg once daily. The dosing should be adjusted according to the individual patient's treatment goals, approximately every 4 weeks.
This medication carries a risk of muscle problems; if severe muscle pain or weakness occurs, discontinue use immediately and consult a physician. This medication should not be used in patients with certain liver diseases or severely impaired liver function. Pregnant or potentially pregnant women, as well as nursing mothers, should not take this medication. Children under 10 years of age should not take this medication, and the safety and effectiveness of long-term use in adolescents under 18 years have not been sufficiently studied. Regular liver function tests are required due to potential impacts on liver function, and symptoms of hepatitis (nausea, vomiting, fatigue, etc.) should be reported to a physician immediately. Caution is required when used by alcoholics, patients with a history of liver disease, renal impairment, and the elderly. Drug interactions may occur when taken with other medications; it is important to inform your physician or pharmacist of any other medications being taken. Special caution is needed when taken in conjunction with certain antibiotics, antifungals, antivirals, blood pressure medications, diabetes medications, and oral contraceptives. Grapefruit juice may increase the blood concentration of this medication, so excessive intake should be avoided. If symptoms such as muscle pain, weakness, fatigue, or fever occur while taking this medication, consult healthcare personnel immediately. Store this medication out of reach of children, and it is safest to keep it in its original container. There is no specific antidote for overdose; treatment should be provided based on symptoms, and liver function and muscle condition should be closely monitored.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, consciousness confusion, visual disturbances, paralysis, and urinary symptoms.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to avoid exposure to air or moisture. It is best kept at room temperature between 1°C and 30°C to safely maintain the drug's effectiveness.
White oval film-coated tablet
30 tablets, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.